Today we are introducing AskEllyn, the world's first AI companion designed specifically to support breast cancer patients through every stage of their journey. AskEllyn represents a new category of AI -- one built not just with intelligence, but with empathy at its core. It is the product of deep collaboration between technologists, oncology professionals, and survivors who understand what patients truly need during the most difficult moments of their lives.
Built on Lived Experience
Most AI products begin with a technical capability and search for a use case. AskEllyn started the other way around. The project began with hundreds of hours of conversations with breast cancer survivors, caregivers, and healthcare providers. We listened to the questions patients asked at 2 a.m. when no one was available. We studied the gaps between clinical information and the emotional reality of a diagnosis. We mapped the journey from initial screening through treatment, recovery, and beyond.
The result is an AI companion that understands not just the medical vocabulary of breast cancer, but the emotional landscape that surrounds it. AskEllyn can help a newly diagnosed patient understand what their pathology report means. It can walk someone through what to expect before their first chemotherapy session. And it can simply be present -- offering reassurance and validated information -- when the weight of uncertainty feels overwhelming.
A New Category of AI
AskEllyn is not a chatbot, and it is not a diagnostic tool. It occupies a space that has not existed before: an AI companion grounded in clinical accuracy and human empathy. Every response is informed by peer-reviewed medical literature and reviewed by oncology professionals, but the tone and approach are shaped by the real experiences of people who have walked this path.
We built AskEllyn on Gambit Cloud's worker architecture, which means it benefits from the same enterprise-grade reliability, data privacy, and continuous learning capabilities that power our commercial AI workers. Patient conversations are never used for training without explicit consent, and all data is encrypted and isolated by design.
Global Access, Personal Touch
Breast cancer affects 2.3 million people worldwide every year, and access to support varies enormously depending on geography, language, and socioeconomic circumstances. AskEllyn is designed to be available to anyone with an internet connection, in multiple languages, at any hour. It does not replace the irreplaceable value of human support networks, but it fills the gaps that exist when professional guidance is not immediately accessible.
We believe AI should be measured not just by what it can do, but by who it can help. AskEllyn is our answer to that belief -- a purpose-built AI companion that puts patients first, always.
